Hot off the press: The biomarker operations and biospecimen community finally has its own dedicated forum.
Introducing the inaugural Biomarker Operations & Biospecimen Management Summit, the industry’s first, purpose-built meeting for the heads, VPs and leading stakeholders at pharma and biotech directly responsible for biospecimen and biomarker delivery.
View the newly released agenda: https://ter.li/p9sor70u
Answering the industry’s call to unite those collecting, tracking and/or translating biospecimen data, this meeting arrives at a pivotal moment.
You can expect to join 80+ experts to strategize on:
- Elevating pre-analytical quality and site collection practices, protecting biomarker signal integrity from the very first draw
- Securing and storing biospecimens for the long term, building acquisition, biobanking, and disposition strategies that balance cost, compliance, and future scientific value
- Streamlining biosample logistics, kit management and vendor sourcing, cutting waste and tracking errors so every sample reaches the right lab, on time
- Navigating consent complexity and evolving regulation, including IVDR and ICH E6(R3), to keep biospecimens compliant and usable for research, long after collection
- Embedding FAIR data principles and AI-driven automation into biomarker workflows, replacing manual reconciliation with systems that accelerate decision-making
Alongside this, hear best-in-class strategies from AstraZeneca, Regeneron, Moderna, BioNTech, and Bristol Myers Squibb and real-time updates from Biospecimen Management Consortium (BMC).
Join us in collaboratively building the future playbook that will define the standards for precision medicine therapies.
Registration is complimentary* for qualifying biopharma and researchers. Visit the website to reserve your spot: https://ter.li/6v47cb7t